Lagerstandorte

New Jersey, USA
Czech Republic, EU
Mumbai, India

* Vorbehaltlich Verfügbarkeit

Dokumentation

MSDS herunterladen

Beispiel-COA herunterladen

Enthält: HPLC, MASS/LC-MS, 1H-NMR, FT-IR, Gehalt, Structure Elucidation Report (SER) sowie zusätzliche analytische Daten je nach Produkt.

267668-71-3Abacavir EP Impurity D (HCl Salt)

● Auf Lager

Katalog-Nr.::	VL760005
CAS-Nr.::	267668-71-3
Summenformel::	C14H20Cl2N6O
Molare Masse::	359.25 g/mol

Angebot anfordern

Zur RFQ-Liste hinzufügen

Zusätzliche Informationen zu CAS 267668-71-3

Parent drug

Abacavir

IUPAC-Name

(1R, 4R)-4-[2-Amino-6-(cyclopropylamino)-9H-purin-9-yl]cyclopent-2-enyl]methanol dihydrochloride

Pharmakopöe-Synonyme

trans Abacavir

Other Synonyms

{(1R,4R)-4-[2-Amino-6-(cyclopropylamino)-9H-purin-9-yl]cyclopent-2-en-1-yl}methanol–hydrogen chloride (1/2); Rel-((1R,4R)-4-(2-amino-6-(cyclopropylamino)-9H-purin-9-yl)cyclopent-2-en-1-yl)methanol dihydrochloride; [(1R,4R)-4-[2-amino-6-(cyclopropylamino)purin-9-yl]cyclopent-2-en-1-yl]methanol dihydrochloride

Beschreibung

Also known as Abacavir Related Compound 8 or trans-Abacavir Dihydrochloride, it is formed by the degradation of Abacavir. Abacavir is an antiretroviral drug that acts by decreasing viral load and increasing CD4+ cell count in HIV-infected patients.

References

Foster RH, Faulds D. Abacavir. Drugs. 1998 May;55(5):729-36; discussion 737-8. DOI: 10.2165/00003495-199855050-00018. PMID: 9585869. Kurmi, Moolchand, et al. “Stability Behaviour of Antiretroviral Drugs and Their Combinations. 5: Characterization of Novel Degradation Products of Abacavir Sulfate by Mass and Nuclear Magnetic Resonance Spectrometry.” Journal of Pharmaceutical and Biomedical Analysis, vol. 134, Feb. 2017, pp. 372–84, https://doi.org/10.1016/j.jpba.2016.10.019.